BridgeMD
New treatment option for Post-traumatic Stress Disorder (PTSD)
Official title Blended Trauma-Focused Cognitive Behavioral Therapy With Compassion
ClinicalTrials.gov ID: NCT07407946
What this study is testing
- What it's testing
- Brief Summary The goal of this clinical trial is to evaluate the feasibility and acceptability of a blended (mHealth) Trauma-Focused Cognitive Behavioral Therapy with Compassion (bTF-CBT-C) for adolescents with post-traumatic stress disorder (PTSD) in routine child and adolescent psychiatric services in northern Sweden. The main questions it aims to answer are: Is bTF-CBT-C feasible to deliver in routine care, as indicated by recruitment, retention, adherence to sessions and app modules, data completeness, and adverse events?
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 17
You may be able to join if
- Adolescents aged 12-17 years.
- Meet DSM-5 criteria for post-traumatic stress disorder (PTSD) confirmed by diagnostic interview (MINI-KID).
- Score ≥25 on the Child and Adolescent Trauma Screen (CATS-2) at baseline.
- Receiving care within routine child and adolescent psychiatric services in participating regions.
- Have a non-offending caregiver willing and able to participate in caregiver components of treatment.
You likely can't join if
- Acute suicidality or risk requiring inpatient care.
- Active psychotic disorder or severe dissociative symptoms that interfere with participation.
- Autism spectrum disorder, severe eating disorder, or obsessive-compulsive disorder requiring primary specialized treatment.
- Ongoing trauma exposure or unstable living conditions that would prevent safe participation.
- Cognitive impairment or medical condition that precludes participation in psychotherapy or digital components.
- Substance use disorder requiring treatment, or regular use of benzodiazepines (\> once per week).
See the full eligibility criteria
- Adolescents aged 12-17 years.
- Meet DSM-5 criteria for post-traumatic stress disorder (PTSD) confirmed by diagnostic interview (MINI-KID).
- Score ≥25 on the Child and Adolescent Trauma Screen (CATS-2) at baseline.
- Receiving care within routine child and adolescent psychiatric services in participating regions.
- Have a non-offending caregiver willing and able to participate in caregiver components of treatment.
- Able to communicate in Swedish sufficiently to engage in treatment and assessments.
- Provide informed assent/consent, with caregiver consent according to age and regulations.
- Acute suicidality or risk requiring inpatient care.
- Active psychotic disorder or severe dissociative symptoms that interfere with participation.
- Autism spectrum disorder, severe eating disorder, or obsessive-compulsive disorder requiring primary specialized treatment.
- Ongoing trauma exposure or unstable living conditions that would prevent safe participation.
- Cognitive impairment or medical condition that precludes participation in psychotherapy or digital components.
- Substance use disorder requiring treatment, or regular use of benzodiazepines (\> once per week).
- Concurrent trauma-focused psychotherapy or recent initiation/discontinuation of psychotropic medication (within the past 6 weeks), or planned medication changes during the study period.
The study team makes the final eligibility decision.
Where it's taking place
- Umeå, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Umeå, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.